SS-31, also known as Elamipretide, MTP-131 or Bendavia, is a synthetic mitochondria-targeted tetrapeptide that has been extensively investigated in research involving mitochondrial membranes, cellular bioenergetics and oxidative stress.
With the sequence D-Arg-Dmt-Lys-Phe-NH₂, where Dmt represents 2′,6′-dimethyltyrosine, SS-31 belongs to the Szeto-Schiller family of mitochondria-targeted peptides developed through the work of Hazel Szeto, Peter Schiller and collaborators.
Unlike mitochondria-derived signalling peptides such as MOTS-C, SS-31 is a synthetic research compound designed to interact preferentially with mitochondrial structures.
This research overview examines the biological background of SS-31, its relationship with cardiolipin and the principal areas in which it has been investigated.
What Is SS-31?
SS-31 is a small, cell-permeable peptide investigated for its ability to localise preferentially within mitochondria.
Its alternating aromatic and cationic amino-acid structure contributes to interactions with the mitochondrial inner membrane, particularly with cardiolipin — a phospholipid strongly associated with mitochondrial membrane structure and function.
This mitochondrial localisation distinguishes SS-31 from many conventional research peptides and has made it a widely studied compound in mitochondrial biology.
Why Is Cardiolipin Important?
Cardiolipin is a specialised phospholipid found predominantly within the inner mitochondrial membrane.
It contributes to the organisation and function of proteins involved in oxidative phosphorylation and plays an important role in maintaining mitochondrial membrane architecture.
Changes to cardiolipin composition, organisation or oxidation have been investigated in relation to mitochondrial dysfunction and cellular stress.
SS-31 research has therefore focused heavily on its interaction with cardiolipin and how this relationship may influence mitochondrial behaviour under experimental conditions.
Proposed SS-31 Mechanisms
SS-31 has been investigated through several interconnected mitochondrial pathways. These mechanisms remain areas of continuing research and should be interpreted according to the experimental model in which they were observed.
Cardiolipin Interaction
One of the best-known characteristics of SS-31 is its interaction with cardiolipin within the inner mitochondrial membrane.
Research has examined whether this interaction can influence membrane organisation, electron transport chain function and mitochondrial responses to cellular stress.
This cardiolipin relationship forms an important mechanistic basis for much of the experimental literature surrounding SS-31.
Oxidative Stress
Mitochondria are both important sources and targets of reactive oxygen species (ROS).
Experimental studies involving SS-31 have investigated changes in oxidative-stress markers and mitochondrial oxidative damage under a variety of research conditions.
The Dmt residue within SS-31 has also received particular attention in studies examining the peptide's interaction with oxidative processes.
Electron Transport and Cellular Energy
The mitochondrial electron transport chain plays a central role in establishing the electrochemical gradient required for ATP synthesis.
Because cardiolipin contributes to the organisation of mitochondrial respiratory proteins, researchers have investigated whether SS-31-associated cardiolipin interactions influence electron transport and mitochondrial bioenergetics under conditions of stress.
Experimental studies have reported changes in mitochondrial respiration and ATP-associated measures in a range of preclinical models.
Cytochrome c and Mitochondrial Signalling
Cardiolipin also interacts with cytochrome c, a mitochondrial protein involved in electron transport and cellular signalling pathways associated with apoptosis.
Research has examined how SS-31-associated changes in cardiolipin interactions may influence cytochrome c behaviour and mitochondrial membrane integrity during cellular stress.
Mitochondrial Structure
Mitochondrial morphology is dynamic and can change considerably in response to cellular conditions.
Preclinical studies have investigated SS-31 in models involving altered mitochondrial structure, fragmentation and mitochondrial dysfunction.
These findings have contributed to broader interest in the relationship between mitochondrial membrane organisation and cellular bioenergetics.
Key Areas of SS-31 Research
Ischaemia-Reperfusion Research
SS-31 has been extensively investigated in experimental models of ischaemia-reperfusion injury.
Ischaemia-reperfusion occurs when blood supply returns to tissue following a period of restricted circulation. The resulting cellular environment can produce substantial mitochondrial and oxidative stress.
Preclinical studies across cardiac, renal, hepatic and neurological models have investigated SS-31 in relation to mitochondrial function, oxidative stress and tissue responses during these experimental conditions.
Results from animal and cellular models should not be interpreted as demonstrating equivalent outcomes in humans.
Cardiac Research
Mitochondrial dysfunction is an important area of investigation within cardiovascular research.
SS-31 has been studied in experimental models involving cardiac bioenergetics, mitochondrial structure, oxidative stress and heart failure.
Elamipretide has also progressed into human clinical research. The existence of clinical studies provides additional data about the compound but does not mean that findings from preclinical models have been confirmed as therapeutic outcomes.
Renal Research
The kidneys have substantial energy requirements, making mitochondrial function particularly relevant to renal biology.
SS-31 has been investigated in preclinical models involving renal ischaemia-reperfusion, mitochondrial dysfunction and chronic kidney disease.
Researchers have examined outcomes including mitochondrial function, cellular injury markers and renal physiology within these experimental systems.
Ageing and Mitochondrial Dysfunction
Changes in mitochondrial function are widely investigated as part of biological ageing.
SS-31 research has included aged animal models examining mitochondrial bioenergetics, oxidative stress, physical function and tissue-specific mitochondrial changes.
These studies make SS-31 relevant to experimental ageing research, but they should not be interpreted as evidence that SS-31 produces an anti-ageing effect in humans.
Skeletal Muscle Research
Skeletal muscle has high and variable energy demands and contains extensive mitochondrial networks.
Researchers have therefore investigated SS-31 in experimental models involving skeletal-muscle mitochondrial function, physical performance, muscle ageing and cellular stress.
This research overlaps with wider investigations into mitochondrial biology, metabolism and age-associated physiological change.
SS-31 vs MOTS-C: What's the Difference?
SS-31 and MOTS-C frequently appear within mitochondrial research, but they are fundamentally different research compounds.
SS-31 is a synthetic mitochondria-targeted tetrapeptide investigated particularly for its interactions with cardiolipin, mitochondrial membranes and cellular bioenergetics.
MOTS-C is a naturally occurring mitochondria-derived peptide encoded within mitochondrial DNA and investigated particularly in relation to metabolic signalling, AMPK pathways and mitochondrial-to-nuclear communication.
The distinction is important: their association with mitochondrial research does not mean they operate through identical biological mechanisms.
For a detailed overview of the latter, read our MOTS-C Research Overview.
SS-31 and NAD+ Research
NAD+ is another research subject frequently encountered within the broader field of mitochondrial and cellular-energy biology.
However, NAD+ and SS-31 should not be treated as interchangeable research materials.
NAD+ is an endogenous coenzyme involved in redox reactions and numerous cellular processes, whereas SS-31 is a synthetic peptide investigated particularly in relation to mitochondrial membrane biology and cardiolipin.
Their inclusion within the same research field reflects overlapping interest in cellular bioenergetics rather than an identical mechanism.
Important Considerations When Reading SS-31 Research
SS-31 has a comparatively substantial research literature, but the strength and relevance of individual findings depend heavily on the experimental context.
Researchers should consider:
- Whether findings originate from cellular, animal or human research
- The tissue or experimental model being investigated
- The specific endpoints measured
- The distinction between mechanistic findings and clinical outcomes
- Experimental concentrations and methodology
- Whether findings have been independently reproduced
- The limitations identified by the study authors
Evidence from preclinical models should not automatically be extrapolated to human biology.
SS-31 Research Material: Documentation and Analytical Data
When evaluating SS-31 supplied for laboratory research, researchers should consider the analytical documentation associated with the material rather than relying solely on headline purity claims.
Relevant information may include product identification, chromatographic analysis, mass-spectrometry data and batch-specific documentation where available.
For help interpreting analytical documentation, read our Guide to Reading a Certificate of Analysis (COA).
Available Alpha Peptides® documentation can also be viewed through our Testing & COAs resources.
Storage and Laboratory Handling
Storage and preparation requirements should be evaluated according to the specific research material, formulation and available supporting documentation.
Researchers should refer to the applicable product information and batch documentation when determining appropriate laboratory handling and storage conditions.
For general information, see our Peptide Storage & Handling Guide.
Explore SS-31 Research
Alpha Peptides® supplies SS-31 Research Peptide for laboratory and scientific research.
Researchers exploring related areas can browse our Mitochondrial Research and Longevity Research collections.
Related educational resources include our MOTS-C Research Overview and additional articles within the Alpha Research Library.
SS-31 supplied by Alpha Peptides® is intended strictly for laboratory and scientific research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment or administration.
This article is provided for educational and informational purposes only and does not constitute medical advice, dosage guidance or recommendations for human use.
